Cancer and ageing: rival demons?
The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
Organisms with renewable tissues use a network of genetic pathways and cellular responses to prevent cancer. The main mammalian tumour-suppressor pathways evolved from ancient mechanisms that, in simple post-mitotic organisms, act predominantly to regulate embryogenesis or to protect the germline. The shift from developmental and/or germline maintenance in simple organisms to somatic maintenance in complex organisms might have evolved at a cost. Recent evidence indicates that some mammalian tumour-suppressor mechanisms contribute to ageing. How might this have happened, and what are its implications for our ability to control cancer and ageing?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several lines of evidence indicate that cellular senescence is a potent tumor-suppressive mechanism [ 4 , 9 , 10 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“Despite support for the idea that senescence is a beneficial anticancer mechanism, indirect evidence suggests that senescent cells can also be deleterious and might contribute to age-related pathologies [ 10 , 23 – 25 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“It is a cellular program which acts as a double-edged sword, with both beneficial and detrimental effects on the health of the organism, and considered to be an example of evolutionary antagonistic pleiotropy.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Campisi, 2003
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“Apoptosis and ageing How might apoptosis contribute to ageing? In the somatic tissues of adult complex organisms, apoptosis is important for maintaining tissue homeostasis; defective apoptosis (either too little or too much) is associated with a number of disease”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Research works printed but not linked: 2
- Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999). · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Davenport, J. Tumor-free but not in the clear. Science, SAGE–KE, 2002.
Cited by
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Self-citationCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
“The apoptotic and senescence responses they implement can have cumulative deleterious effects, and thus may also limit longevity by contributing to aging and late-life pathology (Campisi, 2003a).”
BackgroundSelf-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Self-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
Self-citationMechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
“…with both beneficial and detrimental effects on the health of the organism, and thereby considered to be an example of evolutionary antagonistic pleiotropy (Williams, 1957; Kirkwood and Austad, 2000; Campisi, 2003; Giaimo and D’Adda di Fagagna, 2012; Ohtani et al., 2012; Schosserer et al., 2017).”
BackgroundInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275
“The senescence response suppresses the development of cancer (Campisi, 2003; Campisi, 2013), but there ismounting evidence that senescent cells can accumulate with age and cause or contribute to aging phenotypes and pathologies.”
BackgroundSelf-citationp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003
How stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
Senescence and immortalization: Role of telomeres and telomerase
Shay, J. W., & Wright, W. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh296 · Cited by 610
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice
Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S., Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., et al. (2004) · Nature Genetics · doi:10.1038/ng1382 · Cited by 731
Parrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631
“Thus, senescent cells may create a tissue environment that synergizes with mutation accumulation to facilitate the progression of epithelial malignancies (Campisi, 2003; DePinho, 2000; Rinehart and Torti, 1997).”
BackgroundInfluentialSelf-citationSenescent cells as a source of inflammatory factors for tumor progression
Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9220-9 · Cited by 636
“However, because these mechanisms are imperfect, cancer still poses a major challenge to the longevity of such organisms [1, 2].”
BackgroundSelf-citationExpression of p16 INK4a in peripheral blood T‐cells is a biomarker of human aging
Liu, Y., Sanoff, H. K., Cho, H., Burd, C. E., Torrice, C., Ibrahim, J. G., Thomas, N. E., & Sharpless, N. E. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00489.x · Cited by 509
“activation of tumor suppressor mechanisms such as telomere dysfunction and p16 activation (Campisi, 2003; Kim & Sharpless, 2006; Finkel et al., 2007).”
BackgroundAccelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
Varela, I., Cadiñanos, J., Pendás, A. M., Gutiérrez-Fernández, A., Folgueras, A. R., Sánchez, L. M., Zhou, Z., Rodríguez, F. J., Stewart, C. L., Vega, J. A., et al. (2005) · Nature · doi:10.1038/nature04019 · Cited by 466
Cellular senescence: a link between cancer and age-related degenerative disease?
Campisi, J., Andersen, J. K., Kapahi, P., & Melov, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.001 · Cited by 421
“Thus, cellular senescence may be an example of evolutionary antagonistic pleiotropy, suppressing the development of cancer early in life but driving aging and age-related pathology later in life [4].”
BackgroundSelf-citationThe ageing immune system: is it ever too old to become young again?
Dorshkind, K., Montecino-Rodriguez, E., & Signer, R. A. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2471 · Cited by 412
Two faces of p53: aging and tumor suppression
Rodier, F., Campisi, J., & Bhaumik, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm744 · Cited by 398
Self-citationVijg, J., & Suh, Y. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183715 · Cited by 378
The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
Aunan, J. R., Cho, W. C., & Søreide, K. (2017) · Aging and disease · doi:10.14336/ad.2017.0103 · Cited by 373
Genotoxic Stress Abrogates Renewal of Melanocyte Stem Cells by Triggering Their Differentiation
Inomata, K., Aoto, T., Binh, N. T., Okamoto, N., Tanimura, S., Wakayama, T., Iseki, S., Hara, E., Masunaga, T., Shimizu, H., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.037 · Cited by 368
Oxidative Stress, Accumulation of Biological 'Garbage', and Aging
Terman, A., & Brunk, U. T. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.197 · Cited by 363
miR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging
Hackl, M., Brunner, S., Fortschegger, K., Schreiner, C., Micutkova, L., Mück, C., Laschober, G. T., Lepperdinger, G., Sampson, N., Berger, P., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00549.x · Cited by 355
“…to contribute to transcriptional regulation in cell cycle control and tumorigenesis (He et al., 2005), also contributes to transcriptional regulation in senescence and aging, consistent with the known interdependence between senescence and tumorigenesis (Campisi, 2003; Rodier et al., 2007).”
Backgroundp53 — a Jack of all trades but master of none
Junttila, M. R., & Evan, G. I. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2728 · Cited by 345
Sulak, M., Fong, L., Mika, K., Chigurupati, S., Yon, L., Mongan, N. P., Emes, R. D., & Lynch, V. J. (2016) · eLife · doi:10.7554/elife.11994 · Cited by 339
Shortened Telomeres in Circulating Leukocytes of Patients with Chronic Obstructive Pulmonary Disease
Savale, L., Chaouat, A., Bastuji-Garin, S., Marcos, E., Boyer, L., Maitre, B., Sarni, M., Housset, B., Weitzenblum, E., Matrat, M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1398oc · Cited by 322
“Several studies also suggest that telomere shortening may be a risk factor for the development of cancer (13, 14), particularly lung cancer (15, 16).”
BackgroundEvolution in Health and Disease
(2007) · doi:10.1093/acprof:oso/9780199207466.001.0001 · Cited by 320
INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions
Cánepa, E. T., Scassa, M. E., Ceruti, J. M., Marazita, M. C., Carcagno, A. L., Sirkin, P. F., & Ogara, M. F. (2007) · IUBMB Life · doi:10.1080/15216540701488358 · Cited by 312
“Although it ensures tissue repair and regeneration, it also puts tissues at risk of hyperproliferative diseases, the most deadly of which is cancer ( 47 ).”
BackgroundPML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312
Autophagy, organelles and ageing
Terman, A., Gustafsson, B., & Brunk, U. (2007) · The Journal of Pathology · doi:10.1002/path.2094 · Cited by 285
Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study
Musicco, M., Adorni, F., Di Santo, S., Prinelli, F., Pettenati, C., Caltagirone, C., Palmer, K., & Russo, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5ec1 · Cited by 295
MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure
van Almen, G. C., Verhesen, W., van Leeuwen, R. E. W., van de Vrie, M., Eurlings, C., Schellings, M. W. M., Swinnen, M., Cleutjens, J. P. M., van Zandvoort, M. A. M. J., Heymans, S., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00714.x · Cited by 248
Reactive Oxygen Species as Mediators of Cellular Senescence
Colavitti, R., & Finkel, T. (2005) · IUBMB Life · doi:10.1080/15216540500091890 · Cited by 242
“It also underscores the hypothesized biological importance of senescence as a tumor suppressor mechanism ( 40 ).”
BackgroundGurel, B., Lucia, M. S., Thompson, I. M., Goodman, P. J., Tangen, C. M., Kristal, A. R., Parnes, H. L., Hoque, A., Lippman, S. M., Sutcliffe, S., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1126 · Cited by 236
Moro-García, M. A., Mayo, J. C., Sainz, R. M., & Alonso-Arias, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00339 · Cited by 234
“The critical point for cells to enter senescence appears when the size of TRFs reach less than 6 kb (85).”
BackgroundGlucocorticoids suppress selected components of the senescence‐associated secretory phenotype
Laberge, R., Zhou, L., Sarantos, M. R., Rodier, F., Freund, A., de Keizer, P. L. J., Liu, S., Demaria, M., Cong, Y., Kapahi, P., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00818.x · Cited by 229
“There is increasing evidence that the senescence response may be a double-edged sword, having both beneficial and deleterious effects (Campisi, 2003; Adams, 2009; Bartholomew et al., 2009; Coppé et al., 2010) owing to the complexity of the senescent phenotype (Campisi, 2011; Rodier & Campisi,…”
BackgroundSelf-citationVendrov, A. E., Vendrov, K. C., Smith, A., Yuan, J., Sumida, A., Robidoux, J., Runge, M. S., & Madamanchi, N. R. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6221 · Cited by 219
“It is possible that decreased cyclin-dependent kinase activity, in response to events such as increased DNA damage during aging and with increased mitochondrial oxidative stress, increases retinoblastoma protein kinase activity, consequently increasing the activity of E2F transcription factors (10).”
BackgroundBusuttil, R. A., Rubio, M., Dollé, M. E. T., Campisi, J., & Vijg, J. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00066.x · Cited by 208
“Murine cell cultures undergo replicative senescence and immortalization, which are thought to be important in aging and cancer, respectively, and do so much more readily than similarly cultured human cells (Campisi, 2003).”
BackgroundResultInfluentialSelf-citationVariation in the human TP53 gene affects old age survival and cancer mortality
van Heemst, D., Mooijaart, S. P., Beekman, M., Schreuder, J., de Craen, A. J. M., Brandt, B. W., Eline Slagboom, P., & Westendorp, R. G. J. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.001 · Cited by 206
“The threat posed by genome instability is guarded against by, on the one hand, ‘caretaker’ genes which include genes for DNA repair and are considered longevity assurance genes, and, on the other hand, ‘gatekeeper’ genes which include genes for cell death and cell cycle arrest and are considered tumor suppressor genes…”
BackgroundAutophagy, ageing and apoptosis: The role of oxidative stress and lysosomal iron
Kurz, T., Terman, A., & Brunk, U. T. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.013 · Cited by 199
Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
Stegh, A. H. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.643299 · Cited by 194
“6 p53, aging, and stem cells Cancer is an age-related disease [97,98].”
BackgroundActivated p53 suppresses the histone methyltransferase EZH2 gene
Tang, X., Milyavsky, M., Shats, I., Erez, N., Goldfinger, N., & Rotter, V. (2004) · Oncogene · doi:10.1038/sj.onc.1207706 · Cited by 194
“Replicative senescence maintains cells in a state of irreversible growth arrest and has been suggested to suppress tumorigenesis (Yeager et al., 1998; Itahana et al., 2001; Campisi, 2003).”
BackgroundGenetics of Aging in Caenorhabditis elegans
Antebi, A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030129 · Cited by 192
Sun, L.-Q., Lee, D. W., Zhang, Q., Xiao, W., Raabe, E. H., Meeker, A., Miao, D., Huso, D. L., & Arceci, R. J. (2004) · Genes & Development · doi:10.1101/gad.1176104 · Cited by 186
“It has been hypothesized that mechanisms contributing to senescence may protect young organisms from acute death and cancer but predispose them to malignant transformation of somatic cells in later life (Campisi 1996, 2003).”
BackgroundFOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
“…et al., 2006a), which represents an important tumor suppressionmech- anism (Adams, 2009; Braig and Schmitt, 2006; Caino et al., 2009; Campisi, 2000, 2001, 2003, 2005a,b; Campisi, 2011; Campisi and d’Adda di Fagagna, 2007; d’Adda di Fagagna, 2008; Cichowski and Hahn, 2008; Collado…”
Superoxide Dismutase 1 Knock-down Induces Senescence in Human Fibroblasts
Blander, G., de Oliveira, R. M., Conboy, C. M., Haigis, M., & Guarente, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307146200 · Cited by 183
Trougakos, I. P., & Gonos, E. S. (2006) · Free Radical Research · doi:10.1080/10715760600902310 · Cited by 182
Darwinian medicine: a case for cancer
Greaves, M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2071 · Cited by 180
Liang, S., Mele, J., Wu, Y., Buffenstein, R., & Hornsby, P. J. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00588.x · Cited by 176
“Crisis is characteristic of cells with massive DNA damage, often, but not exclusively, resulting from telomere dysfunction (Counter et al., 1992; Shay et al., 1993; Lustig, 1999; Chang et al., 2003).”
BackgroundThe Transcription Factor FOXM1 (Forkhead box M1)
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 176
The lncRNA MIR31HG regulates p16INK4A expression to modulate senescence
Montes, M., Nielsen, M. M., Maglieri, G., Jacobsen, A., Højfeldt, J., Agrawal-Singh, S., Hansen, K., Helin, K., van de Werken, H. J. G., Pedersen, J. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7967 · Cited by 173
Cancer in rodents: does it tell us about cancer in humans?
Anisimov, V. N., Ukraintseva, S. V., & Yashin, A. I. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1715 · Cited by 171
Aging, tumor suppression and cancer: high wire-act!
Campisi, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.024 · Cited by 171
“In addition, because the secretory phenotype of senescent cells can alter the local tissue milieu, senescent cells may also contribute to the hyperproliferative diseases of aging, including—ironically—cancer (Campisi, 1997, 2003a, 2003b).”
BackgroundInfluentialSelf-citationHeat shock proteins and Drosophila aging
Tower, J. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.09.002 · Cited by 168
“One of the first genes suspected of exhibiting antagonistic pleiotropy between developmental stages was mammalian p53, based upon its beneficial function in young animals to prevent cancer, but a possible detrimental effect in old animals by promoting counter-productive cell senescence or apoptosis (Campisi, 2003).”
BackgroundFrasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.12.001 · Cited by 160
Chorioamniotic membrane senescence: a signal for parturition?
Behnia, F., Taylor, B. D., Woodson, M., Kacerovsky, M., Hawkins, H., Fortunato, S. J., Saade, G. R., & Menon, R. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.05.041 · Cited by 163
Aging by epigenetics—A consequence of chromatin damage?
Sedivy, J. M., Gowrishankar, B., & Adams, P. D. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.023 · Cited by 170
“However, as encapsulated within the hypothesis of "antagonistic pleiotropy" [110,111], SAHF and other events that drive senescence might ultimately promote aging by decreasing the long term renewal capacity of tissues.”
BackgroundMolecular mechanisms of the preventable causes of cancer in the United States
Golemis, E. A., Scheet, P., Beck, T. N., Scolnick, E. M., Hunter, D. J., Hawk, E., & Hopkins, N. (2018) · Genes & Development · doi:10.1101/gad.314849.118 · Cited by 153
“While multistep models may explain the dramatic increase in cancer incidence with age, they do not preclude the possibility that complex and potentially reversible aging-related processes might contribute to cancer through systemic changes that favor tumor growth (Campisi 2003, 2013).”
BackgroundCao, L., Kim, S., Xiao, C., Wang, R., Coumoul, X., Wang, X., Li, W. M., Xu, X. L., Soto, J. A. D., Takai, H., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601115 · Cited by 164
“These data demonstrate that DNA damage and/or tumor suppressor gene mutation causes tumor formation and/or premature aging (Vijg and Dolle, 2002; Campisi, 2003; Hasty et al, 2003).”
BackgroundmiR-17–92 cluster: ups and downs in cancer and aging
Grillari, J., Hackl, M., & Grillari-Voglauer, R. (2010) · Biogerontology · doi:10.1007/s10522-010-9272-9 · Cited by 143
“interwoven (Campisi 2003).”
BackgroundGenetics of Longevity and Aging
Vijg, J., & Suh, Y. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104617 · Cited by 142
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging
Matheu, A., Pantoja, C., Efeyan, A., Criado, L. M., Martín-Caballero, J., Flores, J. M., Klatt, P., & Serrano, M. (2004) · Genes & Development · doi:10.1101/gad.310304 · Cited by 138
“An important issue regarding tumor suppression is its interplay with aging (Campisi 2003 ).”
BackgroundBalancing regeneration and cancer
Beausejour, C. M., & Campisi, J. (2006) · Nature · doi:10.1038/nature05221 · Cited by 145
Self-citationCancer and aging: the importance of telomeres in genome maintenance
Rodier, F., Kim, S.-H., Nijjar, T., Yaswen, P., & Campisi, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.012 · Cited by 132
“Both processes are controlled by the p53 tumor suppressor protein [109-113]. p53 is a transcriptional regulator that both transactivates and transrepresses target genes in response to stress [114, 115].”
Self-citationA Molecular Signature Predictive of Indolent Prostate Cancer
Irshad, S., Bansal, M., Castillo-Martín, M., Zheng, T., Aytés, À., Wenske, S., Magnen, C. L., Guarnieri, P., Sumazin, P., Benson, M. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006408 · Cited by 148
“Indeed, whereas the relationship of aging to cancer is long known to be complex (36), the association of aging and cellular senescence is well appreciated for its essential tumorsuppressive role in many cancers (15–18), including prostate cancer (19–21).”
BackgroundGenome instability, cancer and aging
Maslov, A. Y., & Vijg, J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.020 · Cited by 128
Biology of Cancer and Aging: A Complex Association With Cellular Senescence
Falandry, C., Bonnefoy, M., Freyer, G., & Gilson, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1432 · Cited by 128
Aramillo Irizar, P., Schäuble, S., Esser, D., Groth, M., Frahm, C., Priebe, S., Baumgart, M., Hartmann, N., Marthandan, S., Menzel, U., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02395-2 · Cited by 127
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
“…the renewal capacity of tissues by causing proliferative arrest, senescence may also contribute to aging by influencing neighboring cells through secretory molecules and disrupting the integrity and homeostasis of tissues (Campisi, 2003; Sharpless and DePinho, 2004; Parrinello et al., 2005).”
BackgroundMolecular signature of oncogenic ras-induced senescence
Mason, D. X., Jackson, T. J., & Lin, A. W. (2004) · Oncogene · doi:10.1038/sj.onc.1208172 · Cited by 127
“Of note, some of these gene changes have been observed in replicative senescent cells (Shelton et al., 1999; Ly et al., 2000; Campisi, 2003).”
BackgroundInfluentialClassic and novel roles of p53: prospects for anticancer therapy
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andrés, V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.03.002 · Cited by 141
“oncosuppressors and aging [33], p53 gain-of-function can also provoke accelerated aging in some experimental settings.”
BackgroundHormones and growth factors regulate telomerase activity in ageing and cancer
Bayne, S., & Liu, J. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.05.009 · Cited by 132
Ørsted, D. D., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062476 · Cited by 122
Fahey, J. W., Stephenson, K. K., Dinkova-Kostova, A. T., Egner, P. A., Kensler, T. W., & Talalay, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi068 · Cited by 120
DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
Malaquin, N., Carrier-Leclerc, A., Dessureault, M., & Rodier, F. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00094 · Cited by 113
“MINI REVIEW published: 12 March 2015 doi: 10.3389/fgene.2015.00094 Edited by: Antonio Porro, University of Zurich, Switzerland Reviewed by: David Raulet, University of California, Berkeley, USA Alessandra Montecucco,”
BackgroundInfluentialGenes encoding longevity: from model organisms to humans
Kuningas, M., Mooijaart, S. P., van Heemst, D., Zwaan, B. J., Slagboom, P. E., & Westendorp, R. G. J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00366.x · Cited by 124
“In mammals, this extension comes at the cost of increased cancer risk (Campisi, 2003).”
BackgroundExpression of p16INK4a prevents cancer and promotes aging in lymphocytes
Liu, Y., Johnson, S. M., Fedoriw, Y., Rogers, A. B., Yuan, H., Krishnamurthy, J., & Sharpless, N. E. (2011) · Blood · doi:10.1182/blood-2010-09-304402 · Cited by 114
“Therefore, we believe these studies, in aggregate, support the existence of cellular compartments in which expression of p16INK4a predominantly modulates: (1) aging but not cancer (eg, T cells), (2) cancer but not aging (eg, melanocytes and possibly B lymphocytes), or (3) both cancer and aging (eg, HSC, neural stem/pr…”
Systemic DNA damage responses in aging and diseases
Ribezzo, F., Shiloh, Y., & Schumacher, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.005 · Cited by 116
Telomerase and the aging process
Hornsby, P. J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.007 · Cited by 133
“If this is correct, the anti-cancer process may provide an example of antagonistic pleiotropy, the genetic event (repression of TERT) having beneficial effects in early life span and possibly negative effects in late life span (Campisi, 2003).”
Backgroundp53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
Explaining oscillations and variability in the p53-Mdm2 system
Proctor, C. J., & Gray, D. A. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-75 · Cited by 130
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
Goldberg, A. A., Beach, A., Davies, G. F., Harkness, T. A. A., LeBlanc, A. C., & Titorenko, V. I. (2011) · Oncotarget · doi:10.18632/oncotarget.338 · Cited by 119
“Indeed, the age-dependent accumulation of DNA damage and mutations in normal somatic cells (especially in adult stem and progenitor cells) triggers telomere shortening and/or a gradual rise in the expression of the INK4a/ARF locus encoding the p16INK4a and p14ARF/p19ARF tumor suppressor proteins [53-56,58,62].”
InfluentialBulati, M., Caruso, C., & Colonna‐Romano, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.04.001 · Cited by 121
“It is also known that the age-related accumulation of senescent cells represents a favourable environment for the development of proinflammatory age-related diseases (Campisi, 2003, 2011).”
BackgroundMitochondrial oxidative stress causes chromosomal instability of mouse embryonic fibroblasts
Samper, E., Nicholls, D. G., & Melov, S. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00062.x · Cited by 108
“…cause an increase in the level of oxidative and mutagenic DNA lesions (Williams et al ., 1998; Melov et al ., 1999) but no studies have been published on the effect of SOD2 mutations on genomic instability, a hallmark of cancer and premature aging syndromes such as Werner syndrome (Campisi, 2003).”
BackgroundImetelstat (GRN163L) - Telomerase-Based Cancer Therapy
Röth, A., Harley, C. B., & Baerlocher, G. M. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_16 · Cited by 126
“When chromosome ends become too short, DNA damage signals induce a state of repli cative senescence or cell apoptosis (Campisi 2003; d’Adda et al. 2003).”
BackgroundNovel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage
Grillari, J., & Grillari‐Voglauer, R. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.007 · Cited by 118
“This indicates that this cluster is one additional important player not only in the complex regulatory network of cell cycle and tumorigenesis, but also in aging, emphasising that these processes are intricately interwoven (Campisi, 2003).”
Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis
Russell, M., Berardi, P., Gong, W., & Riabowol, K. T. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.01.020 · Cited by 109
Hematopoietic stem cell aging and self-renewal
Dykstra, B. J., & de Haan, G. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0529-9 · Cited by 116
“In addition, since it is thought that many of the same mechanisms that contribute to cellular aging also act as suppressors of neoplastic growth (Campisi 2003, 2005), a better understanding of hematopoietic aging may provide novel avenues to treat leukemias by enhancing or reintroducing intrinsic…”
BackgroundNutrient Sensing and the Oxidative Stress Response
Luo, H., Chiang, H.-H., Louw, M., Susanto, A., & Chen, D. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.02.008 · Cited by 115
“Admittedly, the incidence of cancer increases with aging and these two rival demons are likely to share some common origins, such as oxidative stress [64].”
BackgroundGenetic determinants of exceptional human longevity: insights from the Okinawa Centenarian Study
Willcox, D. C., Willcox, B. J., Hsueh, W., & Suzuki, M. (2006) · AGE · doi:10.1007/s11357-006-9020-x · Cited by 119
“…that at least some aspects of normal aging are the consequence of anti-cancer mechanisms designed to deal with damaged DNA pathways including those that reduce DNA damage levels from exogenous sources, replication errors and by-products of cellular respiration (Mitchell et al. 2003; Campisi 2003).”
BackgroundDoes Damage to DNA and Other Macromolecules Play a Role in Aging? If So, How?
Campisi, J., & Vijg, J. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln065 · Cited by 101
Self-citationMajor cutbacks at chromosome ends
Lansdorp, P. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.004 · Cited by 114
“One possibility is that telomere loss evolved as a mechanism to suppress the growth of tumors in long-lived species, such as humans, but not in small and short-lived animals, such as rodents [47, 48 ].”
BackgroundYee, A. S., Paulson, E. K., McDevitt, M. A., Rieger‐Christ, K., Summerhayes, I. C., Berasi, S. P., Kim, J., Huang, C.-Y., & Zhang, X. (2004) · Gene · doi:10.1016/j.gene.2004.04.004 · Cited by 109
Telomeres and Longevity: Testing an Evolutionary Hypothesis
Haussmann, M. F., & Mauck, R. A. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm244 · Cited by 115
“Thus, telomere shortening is thought to act as both an anticancer mechanism and contribute to the aging process (Campisi 2003; Hornsby 2006).”
BackgroundShort telomeres in short‐lived males: what are the molecular and evolutionary causes?
Jemielity, S., Kimura, M., Parker, K. M., Parker, J. D., Cao, X., Aviv, A., & Keller, L. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00279.x · Cited by 108
Duan, X., Ponomareva, L., Veeranki, S., Panchanathan, R., Dickerson, E., & Choubey, D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0565 · Cited by 95
“The SASP in HDFs and epithelial cells is associated with increased production of proinflammatory cytokines, such as IL-6, IL-8, and IL-1 (3).”
InfluentialControl of cellular senescence by CPEB
Groisman, I., Ivshina, M., Marin, V., Kennedy, N. J., Davis, R. J., & Richter, J. D. (2006) · Genes & Development · doi:10.1101/gad.1438906 · Cited by 94
“Primary mouse cells that lack either of the abovementioned four tumor suppressors are immortal (Campisi 2003; Sherr 2004).”
BackgroundKurz, D. J., Kloeckener-Gruissem, B., Akhmedov, A., Eberli, F. R., Bühler, I., Berger, W., Bertel, O., & Lüscher, T. F. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000222961.24912.69 · Cited by 93
Metadata
- Authors
- Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Nature Reviews Cancer
- Published
- 2003-05
- Volume
- 3
- Issue
- 5
- Pages
- 339-349
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2096846805
- Cited by
- 512
- References
- 158
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 14 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 23 · 2014: 20 · 2013: 19 · 2012: 23
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cancer, aging, tumor suppressor pathways, somatic maintenance, embryonic development
- MeSH terms
- Aging, DNA Repair, Humans, Longevity, Neoplasms, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cellular Senescence, Apoptosis, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.